Simplex Trading, LLC Castle Biosciences Inc Transaction History

Simplex Trading, LLC

$156 Billion
Q1 2025

A detailed history of Simplex Trading, LLC transactions in Castle Biosciences Inc stock. As of the latest transaction made, Simplex Trading, LLC holds 97 shares of CSTL stock, worth $1,650. This represents 0.0% of its overall portfolio holdings.

Number of Shares

Previous 3,064 96.83%

Holding current value

$1,650

Previous $81,000 98.77%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 12, 2025	SELL	$18.76 - $32.72 $55,660 - $97,080	-2,967 Reduced 96.83%	97 $1,000
Q4 2024 Feb 11, 2025	SELL	$26.52 - $34.67 $237,088 - $309,949	-8,940 Reduced 74.48%	3,064 $81,000
Q3 2024 Nov 08, 2024	BUY	$17.4 - $31.47 $208,869 - $377,765	12,004 New	12,004 $342,000
Q1 2024 Apr 25, 2024	BUY	$18.06 - $25.3 $108 - $151	6 New	6 $0
Q3 2023 Nov 01, 2023	BUY	$13.28 - $20.3 $3,452 - $5,278	260 New	260 $4,000
Q1 2023 Apr 27, 2023	BUY	$19.47 - $28.49 $61,096 - $89,401	3,138 New	3,138 $71,000
Q3 2022 Nov 04, 2022	BUY	$22.51 - $34.32 $180,575 - $275,315	8,022 Added 847.99%	8,968 $233,000
Q2 2022 Aug 03, 2022	BUY	$16.0 - $45.99 $15,136 - $43,506	946 New	946 $20,000
Q1 2022 May 02, 2022	SELL	$33.17 - $46.98 $5,871 - $8,315	-177 Closed	0 $0
Q4 2021 Feb 23, 2022	SELL	$39.06 - $67.58 $56,363 - $97,517	-1,443 Reduced 89.07%	177 $7,000
Q2 2021 Aug 12, 2021	BUY	$50.07 - $76.78 $81,113 - $124,383	1,620 New	1,620 $118,000
Q4 2020 Feb 02, 2021	SELL	$43.6 - $73.05 $6,016 - $10,080	-138 Closed	0 $0
Q3 2020 Oct 14, 2020	SELL	$38.47 - $52.03 $384 - $520	-10 Reduced 6.76%	138 $7,000
Q2 2020 Jul 13, 2020	BUY	$27.28 - $43.01 $4,037 - $6,365	148 New	148 $5,000

Others Institutions Holding CSTL

# of Institutions

192

Shares Held

26.6M

Call Options Held

9.5K

Put Options Held

View Full List

About CASTLE BIOSCIENCES INC

Ticker CSTL
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 26,297,000
Market Cap $448M
Description
Castle Biosciences, Inc., a commercial-stage diagnostics company, focuses to provide diagnostic and prognostic testing services for dermatological cancers. Its lead product is DecisionDx-Melanoma, a multi-gene expression profile (GEP) test to identify the risk of metastasis for patients diagnosed with invasive cutaneous melanoma. The company als...

More about CSTL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Simplex Trading, LLC with notifications on news.

Account

Simplex Trading, LLC Castle Biosciences Inc Transaction History